Valérie Boullay
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, TGF-β signaling in diseases, Diabetes, Cardiovascular Risks, and Lipoproteins, Hepatocellular Carcinoma Treatment and Prognosis, Inflammatory Bowel Disease
Most-Cited Works
- → Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors(2004)219 cited
- → Inhibition of TGF‐β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis(2005)164 cited
- → Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist(2015)25 cited
- → Abstract 3228: Immune checkpoint blockade and autoimmune diseases: Development of a mouse model of colitis induced by anti-CTLA-4(2019)2 cited
- → Abstract 5638: Liver preclinical models - acute, chronic and cancer models(2020)